US health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices.

While neither warning is classified as a recall, the FDA has provided additional information for the two products. Boston Scientific told customers that its Endotak Reliance defibrillation leads with ...

Key Takeaways Two Boston Scientific heart devices have been linked to serious injuries and deathsOne device may fail to ...

The FDA has issued an early communication to warn of updated instructions for use for certain Boston Scientific Watchman access systems.

Boston Scientific Corporation (NYSE:BSX) is one of Goldman Sachs’ top healthcare stock picks. On July 7, Boston Scientific (NYSE:BSX) saw its shares rise as TD Cowen reaffirmed its Buy rating ...

Boston Scientific Corporation (NYSE:BSX) is one of the 13 Best Large Cap Stocks to Buy Right Now. On July 7, Boston Scientific Corporation (NYSE:BSX) announced that it has obtained approval to ...

A dozen lawsuits have been filed over spinal cord stimulators, which are medical devices surgically implanted to reduce chronic back pain. The suits name device manufacturers, such as Abbott and ...

Boston Scientific bumped up its financial forecasts for the remainder of this year after reporting double-digit growth across multiple medtech segments. | The company logged a 22.8% increase in ...

Boston Scientific Corporation (NYSE:BSX) is one of the 13 Best Large Cap Stocks to Buy Right Now.

Boston Scientific Corporation (NYSE:BSX) Q2 2025 Earnings Conference Call July 23, 2025 8:00 AM ETCompany ParticipantsJonathan R.

Additionally, Boston Scientific’s FARAPULSE Pulsed Field Ablation (PFA) System has gained FDA approval to treat persistent atrial fibrillation (AF), expanding its use beyond paroxysmal AFib.

Full transcript - Boston Scientific Corp (BSX) Q2 2025: Drew, Conference Operator: Good morning, and welcome to the Boston Scientific Second Quarter twenty twenty five Earnings Call.